Trials / Terminated
TerminatedNCT00819897
Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta
Longitudinal Study in Clinical Isolated Syndrome Patients Treated With Interferon Beta. Correlation With Cognitive Disorders and Quality of Life.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the role of cognitive disorders and quality of life in patients with CIS, considered as high risk to develop an MS, treated with interferon Beta. This prospective observational study will include 120 patients, all treated and evaluated annually with neurological extensive examination, ophthalmologic screening (OCT, OF, VEP, VF), auto questionnaire about fatigue (musicol, ELIF), quality of life (SEP-59), and conventional MRI.
Conditions
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2009-01-09
- Last updated
- 2016-05-12
Locations
17 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00819897. Inclusion in this directory is not an endorsement.